Clinical evaluation [hlca]    
Urinary [bpoc]    
Serum alpha-fetoprotein [lbpr]    
Tumor Markers [bacs]    
HEPATOCELLULAR CARCINOMA [neop]    
Evaluate [hlca]    
Diagnostic [fndg]    
Application [hlca]    
Urinary [bpoc]    
SERUM [bdsu]    
Alpha [inpr]    
Levels [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Patients [podg]    
Cirrhotic [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Sex [orgf]    
matched [resa]    
Patients [podg]    
CIRRHOSIS [dsyn]    
Alone [qnco]    
Levels [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Higher [qlco]    
CIRRHOSIS [dsyn]    
Alone [qnco]    
Inverse [qlco]    
Correlation [qlco]    
Log [inpr]    
R- [spco]    
Indicated [fndg]    
DOSE [qnco]    
Related [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Receiver Operating Characteristic [qnco]    
Curve [spco]    
Optimal [qlco]    
Cutoff [ftcn]    
Values [qlco]    
MU [geoa]    
g/g [qnco]    
NG.1 [gngm]    
Specificity [qnco]    
LIKELIHOOD RATIO [qnco]    
Sensitivity [patf]    
determination [lbpr]    
Marker [clna]    
In [qnco]    
Parallel [qlco]    
Increased [qnco]    
Diagnostic Accuracy [qlco]    
>90 [qnco]    
Sensitivity [patf]    
Specificity [qnco]    
LIKELIHOOD RATIO [qnco]    
Independent [idcn]    
Tumor Markers [bacs]    
HEPATOCELLULAR CARCINOMA [neop]    
Tumor Markers [bacs]    
Discriminate [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
CIRRHOSIS [dsyn]    
